Angiotensin II Receptor Blockers Market 2019-2026 Future Trends And SWOT Analysis By Industry Top Players: AstraZeneca, Novartis, Abbvie, Lupin, Novartis, Abbvie, Takeda, Zydus Cadila

Angiotensin II Receptor Blockers Market Size – USD 7.29 Billion in 2018, Market Growth - CAGR of 3.5%, Market Trends – Product launches and research for advanced hypertension care
The Angiotensin II receptor blockers market is projected to grow at a CAGR of 3.5%, in terms of value, from USD 7.29 Billion in 2018 to reach USD 9.61 Billion by 2026. This class of drug is used to block angiotensin II effects, and thus prevents the narrowing of blood vessels by angiotensin II action. The Angiotensin II receptor blockers facilitates widening of blood vessels and reduce blood pressure in an individual. In general, Angiotensin II receptor blockers are prescribed for patients with intolerance for angiotensin-converting-enzyme inhibitor.

The key factors contributing to the market growth includes increasing incidence of hypertension, chronic kidney diseases, kidney failure in diabetes, and heat failure, across the globe. For instance, according to American Heart Association statistics 2018, more than 103 million individuals in U.S. suffer from high blood pressure However, associated side effects (such as severe dizziness, insomnia, diarrhea, irregular heartbeat, and confusion) are the major hindrance for market growth during 2019-2026.

In market segmentation by manufacturers, the Angiotensin II Receptor Blockers report covers the following
AstraZeneca, Daichii Sankyo, Novartis, Abbvie, Lupin, Novartis, Abbvie, Takeda, AstraZeneca, and Zydus Cadila and others

Premium sample copy of Angiotensin II Receptor Blockers market report available on demand@ https://www.reportsanddata.com/sample-enquiry-form/1156

Angiotensin II Receptor Blockers Market split by Product, can be divided into:
• Azilsartan
• Candesartan
• Eprosartan
• Irbesartan
• Losartan
• Olmesartan
• Telmisartan
• Valsartan

Angiotensin II Receptor Blockers Market By Application, can be divided into:
• Hypertension
• Cardiovascular risks
• Kidney failure in diabetes
• Chronic kidney diseases

Order Now (Customized report delivered as per your requirement)@ https://www.reportsanddata.com/checkout-form/1156

Further key findings from the report suggest:
• Angiotensin II Receptor Blockers market is rising at a growth rate of 4.4 percent in Asia Pacific followed by North America and Europe, with 3.4% and 3.2% CAGR respectively. Rising geriatric population in the region and rising obese population in the region will drive the demand for the market during forecast period across all regions.
• Increasing incidence of hypertension & cardiovascular diseases in younger population are likely to contribute to the overall market growth.
• Valsartan is the leading Angiotensin II Receptor Blocker in the market with market share of 20.8%. The Valsartan market was valued at USD 1.51 billion and is expected reach USD 1.97 billion by 2026. However, recalls of valsartan during 2018 and 2019, due to cancer concerns is a major challenge for the market growth of this market segment.
• Azilsartan is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 4.5%.
• Asia Pacific is expected to witness a CAGR of 6.5 percent in the forecast period. Emerging markets such China and Japan are likely to witness high growth
• The lack of well-established medical reimbursements for hypertension in various developing regions is likely to hinder the market growth
• Key participants include AstraZeneca, Daichii Sankyo, Novartis, Abbvie, Lupin, Novartis, Abbvie, Takeda, AstraZeneca, and Zydus Cadila.
•

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:
• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

In this study, the years considered to estimate the market size of Angiotensin II Receptor Blockers are as follows:
History Year:2017
Base Year: 2018
Forecast Year 2019 to 2026

The Angiotensin II Receptor Blockers further aims at providing insight into:
• The major industry terms and forecasts the Angiotensin II Receptor Blockers, in terms of growth rate, value as well as segmentation on the basis of technology advancements, application share, and geography.
• The market size across major regions including North America, Asia Pacific, Europe, as well as Rest of the World.
• The micro markets with regards to company growth, prospects, as well as a contribution to the Angiotensin II Receptor Blockers industry.
• Data regarding the major drivers, restraining factors, challenges and opportunities affecting the growth rate of the industry.
• Information about growing investment pockets and competitive landscape for prominent players in the industry.
• The value chain pertaining to the Angiotensin II Receptor Blockers market.

The report provides answers to the questions below:
• `What will be the status of competitive development including expansion, product and service launches and other developments?
• How much funds are major companies rolling out for their research and development activities in the Angiotensin II Receptor Blockers space?
• Based on the end user, which category of the Angiotensin II Receptor Blockers is projected to grow rapidly at the highest CAGR from 2019 to 2026?
• Among product and service types, which segment will lead the Angiotensin II Receptor Blockers industry during the forecast period?
• Which region is expected to make more sales from 2019 to 2026?

Key Points From TOC:
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
Chapter 4. Angiotensin II Receptor Blockers Market Segmentation & Impact Analysis
Chapter 5. Angiotensin II Receptor Blockers Market By Type of Service Insights & Trends
Chapter 6. Angiotensin II Receptor Blockers Market By Industry Verticals Insights & Trends
Chapter 7. Angiotensin II Receptor Blockers Market By Size of Organization Insights & Trends
Chapter 8. Angiotensin II Receptor Blockers Market Regional Outlook
Chapter 9. Competitive Landscape
Chapter 10. Company Profiles

Browse complete Angiotensin II Receptor Blockers report description And Full TOC@ https://www.reportsanddata.com/press-release/global-angiotensin-ii-receptor-blockers-market

About Reports and Data
Reports and Data. is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John Watson
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

This release was published on openPR.